This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

IV. Influence of Toxic Substances and Enzyme Inhibitors

WALTER KORNBLUETH, M.D.; EDNA BEN-SHLOMO, M.A.

AMA Arch Ophthalmol. 1956;55(6):813-817.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Since carbohydrates are the main source of energy of the retina, it was thought that the glucose uptake of the retina might be an indicator of chemical damage to the retinal metabolism.

This report deals with the influence on the glucose uptake of the retina of some substances which are known to cause toxic amblyopia (methyl alcohol, quinine, arsenicals) and of compounds which damage the visual cells (iodoacetic acid, sodium iodate). Because of the close relationship of the carbohydrate metabolism to the resynthesis of acetylcholine, it was thought that cholinesterase inhibitors might influence the glucose uptake of the retina. Therefore the effects of physostigmine and isoflurophate (DFP; diisopropyl fluorophosphate) were investigated. Since a high concentration of carbonic anhydrase is present in the retina,¹ the influence of the carbonic anhydrase inhibitor acetazoleamide (Diamox) was tested. The effects of ethionine, a competitive antagonist of methionine, and of the folic acid antagonist . . . [Full Text PDF of this Article]

Author Affiliations
Jerusalem

From the Department of Ophthalmology, Rothschild-Hadassah-University Hospital, and the Department of Pathological Physiology of the Hebrew University Medical School.

Footnotes
Received for publication Feb. 20, 1955.

This work was supported by a grant from the Ben May Fund.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?